Crispr Therapeutics shares owned by Principal Financial Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Principal Financial Group
from 13F filings
Historical chart of Principal Financial Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Principal Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Principal Financial Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.8M | 41k | 68.16 |
| 2022-09-30 | $592k | 9.1k | 65.35 |
| 2022-06-30 | $534k | 8.8k | 60.72 |
| 2022-03-31 | $553k | 8.8k | 62.73 |
| 2021-12-31 | $694k | 9.2k | 75.77 |
| 2021-09-30 | $1.7M | 15k | 111.96 |
| 2021-06-30 | $2.9M | 18k | 161.89 |
| 2021-03-31 | $1.9M | 16k | 121.87 |